Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New tocolytics from Merck & Co.

Sep. 20, 1996

New combination for contraception in males

Sep. 20, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

Vivus seeks approval for impotence treatment

Sep. 20, 1996

Tulane U. investigates GHRH agonists

Sep. 20, 1996

New use for 5-HT2 antagonist

Sep. 20, 1996

Troglitazone nearing launch

Sep. 20, 1996

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Immunex issued first patent on blood stem cell factor

Sep. 20, 1996

New indication claimed for EPO

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...